Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 14 May 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Consolidated net sales are expected to increase because overseas sales rose in local-currency terms and benefited from the weaker yen. On the profit side, operating income, ordinary income and net income attributable to owners of the parent are all expected to fall below the previous forecast because gross profit declined as a result of lower non-consolidated net sales, while SG&A expenses increased because of the weaker yen and exceeded plan. On a non-consolidated basis, net sales of the core insecticide business fell below forecast because unfavorable weather at the beginning of the fiscal year delayed the market launch and price increases reduced sales volumes. The resulting decline was not offset by profit improvements from the price increases or reductions in SG&A expenses. In addition, an allowance for doubtful accounts was recognized as an extraordinary loss for part of loans to a domestic subsidiary.
An allowance for doubtful accounts was recognized for part of loans to a domestic subsidiary. Amount: Not disclosed.
| Item | Details |
|---|---|
| Net Sales | Consolidated 77,100 / Individual 26,500 → Consolidated 77,366 / Individual 24,055（Consolidated 0.3 / Individual -9.2） |
| Operating profit | Consolidated 2,900 / Individual Not disclosed → Consolidated 2,190 / Individual Not disclosed（Consolidated -24.5 / Individual Not disclosed） |
| Ordinary income | Consolidated 2,980 / Individual 1,450 → Consolidated 2,262 / Individual 1,109（Consolidated -24.1 / Individual -23.5） |
| Profit attributable to owners of the parent | Consolidated 1,960 / Standalone (net income) 1,400 → Consolidated 1,206 / Standalone (net income) 888（Consolidated -38.4 / Standalone (net income) -36.5） |
| Net income per share | Consolidated 118.96 / Individual 84.94 → Consolidated 73.24 / Individual 53.94 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 May 2025 |
| Previous-period results | Consolidated Net Sales 73,854 / Operating profit 2,646 / Ordinary income 2,520 / Profit attributable to owners of the parent 1,462 / Net income per share 88.77 / Individual Net Sales 25,542 / Ordinary income 1,146 / Net income for the current fiscal year 1,010 / Net income per share 61.33 |
| Reason for the revision | Consolidated net sales are expected to increase because overseas sales rose in local-currency terms and benefited from the weaker yen. On the profit side, operating income, ordinary income and net income attributable to owners of the parent are all expected to fall below the previous forecast because gross profit declined as a result of lower non-consolidated net sales, while SG&A expenses increased because of the weaker yen and exceeded plan. On a non-consolidated basis, net sales of the core insecticide business fell below forecast because unfavorable weather at the beginning of the fiscal year delayed the market launch and price increases reduced sales volumes. The resulting decline was not offset by profit improvements from the price increases or reductions in SG&A expenses. In addition, an allowance for doubtful accounts was recognized as an extraordinary loss for part of loans to a domestic subsidiary. |
| Details and amount of extraordinary loss | An allowance for doubtful accounts was recognized for part of loans to a domestic subsidiary. Amount: Not disclosed. |
| Consolidated / non-consolidated | Consolidated/non-consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Consolidated net sales are expected to exceed the previous forecast because overseas sales increased in local-currency terms, compounded by the impact of the weaker yen. Profit is expected to fall below the previous forecast due to lower gross profit resulting from the decline in non-consolidated net sales, SG&A expenses exceeding plan because of the weaker yen, and lower sales volumes of insecticides caused by unfavorable weather at the beginning of the fiscal year and price increases. In addition, the recognition of an allowance for doubtful accounts as an extraordinary loss for part of loans to a domestic subsidiary was another factor behind the decline in non-consolidated net income.